GlobalData estimates the 2012 sales for opioid-induced constipation (OIC) to be approximately $144.42m across the six major pharmaceutical markets covered in this forecast: the US, France, Germany, Italy, Spain, and the UK. The EU contributed the majority of these sales, …
This new report provides strategic directions of global flavor and fragrance companies. The report presents:
- Business goals and strategies, including internal expansion, acquisitions, and divestitures.
- Specific business, new product development and marketing objectives and strategies.
- Major strengths and weaknesses.
- Anticipated acquisitions, joint ventures and divestitures.
The companies analyzed in the report: Firmenich, Givaudan, T. Hasegawa, IFF, Mane, Quest, Robertet, Sensient, Symrise, and Takasago